Communication
Press releases
- 08/09/2010 Almirall awarded the “zero rate” for accident frequency in 2009
- 30/07/2010 First Half 2010 in line with guidance, strong R&D catalysts expected in second half
- 28/07/2010 Sativex® receives regulatory authorisation in Spain
- 26/07/2010 Almirall signs a co-promotion agreement with Pfizer to commercialise Conbriza® in Spain, a new therapeutic option to treat osteoporosis
Optimized for Internet Explorer